Lung (A549), prostate (PC-3 and DU-145), neuroblastoma (IMR-32), breast cancer (MCF-7), ovary (IGR-OV-1), acute lymphoblastic leukemia (HL-60), leukemia (THP-1), liver (HEP-2), colon (Colo-205, HCT-15, Caco-2), and cervix (Hela) are some of the cell lines used to study the cytotoxicity of herbal drugs using in vitro cytotoxicity assays like SRB and MTT.
Lung (A549), prostate (PC-3 and DU-145), neuroblastoma (IMR-32), breast cancer (MCF-7), ovary (IGR-OV-1), acute lymphoblastic leukemia (HL-60), leukemia (THP-1), liver (HEP-2), colon (Colo-205, HCT-15, Caco-2), and cervix (Hela) are some of the cell lines used to study the cytotoxicity of herbal drugs using in vitro cytotoxicity assays like SRB and MTT.
It will depend on whether you are evaluating the cytotoxicity along with a bioactivity. If you are showing a particular bioactivity for the extracts then you should evaluate cytotoxicity in one of the related cell line. For an example if you are showing hepatoprotective activity then you should choose a liver cell line for cytotoxicity evaluation. Also if you want to show a systemic toxicilty you might pick a panel of cell lines from various end organs like liver brain kidney heart etc.
Other than these, many other literature references are available which are relevant with your query. Just google them out. You will find answers in detail (some pdf's are also available) regarding your query.
If i am working on RAW cell lines of macrophages then Is it necessary to carry put cytotoxicity on the same cell lines? Or some other cell lines like Vero?
Dear Sir, you can test toxicity in all cancer cell lines, also on transformed cell lines, because they are different in origin, also found normal cell lines.